Dr. Anthony Fauci says it’s probably already in the US. Pfizer and Moderna are now testing their vaccines to see if they work against the UK variant, though experts have said they still expect the vaccines to be effective.
A variant occurs when the genetic structure of a virus changes. All viruses mutate over time and new variants are common, including for the novel coronavirus.
Where did the variant originate and how has it taken hold?
The new variant is believed to have originated in southeast England, according to the WHO. Public Health England (PHE) says backwards tracing, using genetic evidence, suggests the variant first emerged in England in September. It then circulated in very low levels until mid-November.
“The increase in cases linked to the new variant first came to light in late November when PHE was investigating why infection rates in Kent [in southeast England] were not falling despite national restrictions. We then discovered a cluster linked to this variant spreading rapidly into London and Essex,” PHE said.
But Sharon Peacock, professor of public health and microbiology at the University of Cambridge, said scientists did not know whether the mutation had originated in southeast England or whether it was introduced there from elsewhere.
Speaking at a press briefing on Tuesday, Peacock also praised the strength of the UK’s genetic surveillance operation. “If you’re going to find [a variant] anywhere, you’re going to find it probably here first,” she said. “And if this occurs in places that don’t have any sequencing, you’re not going to find it at all unless you’re using [other methods.]”
Whitty said Saturday the variant was responsible for 60% of new infections in London, which have nearly doubled in the last week alone.
Some experts have suggested that this new variant could have been amplified because of a superspreader event, meaning the current spike in cases could also have been caused by human behavior.
“When we first started to see this enormous rise, it could have been a number of things. It could have been [due to] changes in behavior,” said Judith Breuer, professor of virology at UCL, during a briefing on Tuesday.
“[But now] it is very clear that there is a significant rise in the prevalence of this variant and that this is likely to be due to biological features of the variant and indeed increased transmissability.”
Which countries are affected?
The variant has already spread globally. As well as the UK, the variant has also been detected in Denmark, Belgium, the Netherlands and Australia, according to the WHO.
Australia has identified two cases of the variant in a quarantined area in Sydney and Italy has also identified one patient infected with the variant.
A similar but separate variant has also been identified in South Africa, where scientists say it is spreading quickly along coastal areas of the country.
Is the new variant more deadly?
There is no evidence as of now to suggest that the new variant is more deadly, according to Whitty and the WHO, though it is too early to tell.
Several experts have noted that in some cases, virus mutations that increase transmissibility are accompanied by a drop in virulence and mortality rates.
“As viruses are transmitted, those that allow for increased virological ‘success’ can be selected for, which changes the properties of the virus over time. This typically leads to more transmission and less virulence,” Martin Hibberd, professor of emerging infectious disease at the London School of Hygiene & Tropical Medicine, told the SMC.
Will the developed vaccines work against this variant?
There are no signs yet that the current vaccine frontrunners won’t work against this new variant, experts and drugmakers have said.
The companies behind the first two vaccines to gain authorization in the US — Pfizer/BioNTech and Moderna — are testing their shots to double-check that they’re effective against the variant.
The coronavirus has mutated before, and both firms say their vaccines worked against other variations of the virus.
The CEO of BioNTech said he has “scientific confidence” that the current Pfizer-BioNTech vaccine could work against the new variant, but full data will be available in two weeks.
Ugur Sahin said the new variant may however require countries to vaccinate more of the population, raising the bar for achieving herd immunity.
“[On] the topic of herd immunity there is always the discussion about 60-70%,” Sahin told a news conference Tuesday. “But if the virus becomes more efficient in infecting people, we might need even a high vaccination rate to ensure that normal life can continue without interruption.”
What measures are being taken to contain the variant?
Large swathes of England, including London and the southeast, are now under strict Tier 4 Covid-19 restrictions, and UK government health experts have suggested additional restrictions could be required to beat back this variant.
Dozens of countries across Europe, the Middle East and the Americas have also announced travel bans for the UK, or new testing and quarantine requirements for UK arrivals.
The White House is considering requiring travelers from the UK to present proof of a negative test before arriving in the US, two administration officials have told CNN.
In its press release on Tuesday, the WHO issued a reminder of the basic measures to reduce the transmission of the virus: avoid close contact with people who are infected, wash your hands frequently, and wear a mask.